scholarly journals Adrenaline enhances in vitro platelet activation and aggregation in blood samples from ticagrelor-treated patients

2018 ◽  
Vol 2 (4) ◽  
pp. 718-725 ◽  
Author(s):  
Sukhi Singh ◽  
Carl Johan Malm ◽  
Sofia Ramström ◽  
Camilla Hesse ◽  
Anders Jeppsson
CHEST Journal ◽  
2011 ◽  
Vol 140 (4) ◽  
pp. 991A
Author(s):  
Zechariah Franks ◽  
Robert Campbell ◽  
Andy Weyrich ◽  
Guy Zimmerman ◽  
Matthew Rondina

2005 ◽  
Vol 146 (4) ◽  
pp. 216-226 ◽  
Author(s):  
George Hsiao ◽  
Ying Wang ◽  
Nien-Hsuan Tzu ◽  
Tsorng-Hang Fong ◽  
Ming-Yi Shen ◽  
...  

1993 ◽  
Vol 72 (4) ◽  
pp. 373-375
Author(s):  
Julio B Fernandes ◽  
Ulhas P Naik ◽  
Mariana S Markell ◽  
Elizabeth Kornecki

Cells ◽  
2020 ◽  
Vol 9 (8) ◽  
pp. 1915 ◽  
Author(s):  
Marion Mussbacher ◽  
Teresa L. Krammer ◽  
Stefan Heber ◽  
Waltraud C. Schrottmaier ◽  
Stephan Zeibig ◽  
...  

Blood-derived microRNA signatures have emerged as powerful biomarkers for predicting and diagnosing cardiovascular disease, cancer, and metabolic disorders. Platelets and platelet-derived microvesicles are a major source of microRNAs. We have previously shown that the inappropriate anticoagulation and storage of blood samples causes substantial platelet activation that is associated with the release of platelet-stored molecules into the plasma. However, it is currently unclear if circulating microRNA levels are affected by artificial platelet activation due to suboptimal plasma preparation. To address this issue, we used a standardized RT-qPCR test for 12 microRNAs (thrombomiR®, TAmiRNA GmbH, Vienna, Austria) that have been associated with cardiovascular and thrombotic diseases and were detected in platelets and/other hematopoietic cells. Blood was prevented from coagulating with citrate–theophylline–adenosine–dipyridamole (CTAD), sodium citrate, or ethylenediaminetetraacetic acid (EDTA) and stored for different time periods either at room temperature or at 4 °C prior to plasma preparation and the subsequent quantification of microRNAs. We found that five microRNAs (miR-191-5p, miR-320a, miR-21-5p, miR-23a-3p, and miR-451a) were significantly increased in the EDTA plasma. Moreover, we observed a time-dependent increase in plasma microRNAs that was most pronounced in the EDTA blood stored at room temperature for 24 h. Furthermore, significant correlations between microRNA levels and plasma concentrations of platelet-stored molecules pointed towards in vitro platelet activation. Therefore, we strongly recommend to (i) use CTAD as an anticoagulant, (ii) process blood samples as quickly as possible, and (iii) store blood samples at 4 °C whenever immediate plasma preparation is not feasible to generate reliable data on blood-derived microRNA signatures.


1998 ◽  
Vol 39 (4) ◽  
pp. 349-354 ◽  
Author(s):  
K. S. Sakariassen ◽  
R. M. Barstad ◽  
M. J. A. G. Hamers ◽  
H. Stormorken

Background: The nonionic monomer iohexol triggers in vitro platelet secretion of β-thromboglobulin (β-TG). This iohexol platelet activation may promote intravascular thrombosis. We studied this relationship by employing a human model of collagen-induced platelet thrombus formation at arterial flow. The ionic dimer ioxaglate, the nonionic dimer iodixanol, and glucose were included. Methods and Results: In vitro platelet activation as measured by β-TG secretion following a 1-min incubation of native blood with 50 vol% of iohexol was significant. Glucose solutions of 300, 580 and 825 mosmol, corresponding to the osmolalities of respectively iodixanol, ioxaglate and iohexol, increased the β-TG secretion in parallel with the osmolalities. Ioxaglate and iodixanol were virtually inert. Continuous infusion of iohexol or 580 or 825 mosmol glucose (40 vol%) into flowing native blood at an arterial wall shear rate of 2600 s−1 in an ex vivo collagen-induced platelet thrombus formation device triggered pronounced secretion of β-TG. However, the platelet thrombus formation in blood mixed with iohexol was within the same range as that observed with ioxaglate or iodixanol. Increasing glucose osmolality induced increasing β-TG secretion, which paralleled gradually decreasing platelet thrombus formation. Conclusion: Iohexol and 580 or 825 mosmol glucose trigger platelet secretion of β-TG. This secretion is not associated with enhanced collagen-induced platelet thrombus formation at high arterial shear.


1991 ◽  
Vol 62 (5) ◽  
pp. 429-439 ◽  
Author(s):  
Shosaku Nomura ◽  
Hirokazu Nagata ◽  
Masahiko Suzuki ◽  
Koji Kondo ◽  
Shigetoshi Ohga ◽  
...  

Life Sciences ◽  
2019 ◽  
Vol 233 ◽  
pp. 116700 ◽  
Author(s):  
Yun Wang ◽  
Ya-ping Wu ◽  
Ji-ju Han ◽  
Mao-qing Zhang ◽  
Chen-xi Yang ◽  
...  

2010 ◽  
Vol 8 (8) ◽  
pp. 1809-1819 ◽  
Author(s):  
P. STARLINGER ◽  
H. P. MOLL ◽  
A. ASSINGER ◽  
C. NEMETH ◽  
K. HOETZENECKER ◽  
...  

2003 ◽  
Vol 22 (4) ◽  
pp. 365-373 ◽  
Author(s):  
Kouichirou Shigeta ◽  
Nobuyuki Taniguchi ◽  
Kiyoka Omoto ◽  
Seiji Madoiwa ◽  
Yoichi Sakata ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document